Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease - PubMed (original) (raw)
Review
doi: 10.4161/auto.5604. Epub 2008 Jan 18.
Affiliations
- PMID: 18216494
- DOI: 10.4161/auto.5604
Free article
Review
Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease
Simone Engelender. Autophagy. 2008 Apr.
Free article
Abstract
alpha-Synuclein is mutated in Parkinson's disease (PD) and is found in cytosolic inclusions, called Lewy bodies, in sporadic forms of the disease. A fraction of alpha-synuclein purified from Lewy bodies is monoubiquitinated, but the role of this monoubiquitination has been obscure. We now review recent data indicating a role of alpha-synuclein monoubiquitination in Lewy body formation and implicating the autophagic pathway in regulating these processes. The E3 ubiquitin-ligase SIAH is present in Lewy bodies and monoubiquitinates alpha-synuclein at the same lysines that are monoubiquitinated in Lewy bodies. Monoubiquitination by SIAH promotes the aggregation of alpha-synuclein into amorphous aggregates and increases the formation of inclusions within dopaminergic cells. Such effect is observed even at low monoubiquitination levels, suggesting that monoubiquitinated alpha-synuclein may work as a seed for aggregation. Accumulation of monoubiquitinated alpha-synuclein and formation of cytosolic inclusions is promoted by autophagy inhibition and to a lesser extent by proteasomal and lysosomal inhibition. Monoubiquitinated alpha-synuclein inclusions are toxic to cells and recruit PD-related proteins, such as synphilin-1 and UCH-L1. Altogether, the new data indicate that monoubiquitination might play an important role in Lewy body formation. Decreasing alpha- synuclein monoubiquitination, by preventing SIAH function or by stimulating autophagy, constitutes a new therapeutic strategy for Parkinson's disease.
Similar articles
- α-Synuclein fate is determined by USP9X-regulated monoubiquitination.
Rott R, Szargel R, Haskin J, Bandopadhyay R, Lees AJ, Shani V, Engelender S. Rott R, et al. Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18666-71. doi: 10.1073/pnas.1105725108. Epub 2011 Nov 7. Proc Natl Acad Sci U S A. 2011. PMID: 22065755 Free PMC article. - Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E, Eyal A, Avraham E, Shemer R, Szargel R, Berg D, Bornemann A, Riess O, Ross CA, Rott R, Engelender S. Liani E, et al. Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5500-5. doi: 10.1073/pnas.0401081101. Epub 2004 Apr 2. Proc Natl Acad Sci U S A. 2004. PMID: 15064394 Free PMC article. - Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.
Szargel R, Rott R, Eyal A, Haskin J, Shani V, Balan L, Wolosker H, Engelender S. Szargel R, et al. J Biol Chem. 2009 Apr 24;284(17):11706-16. doi: 10.1074/jbc.M805990200. Epub 2009 Feb 17. J Biol Chem. 2009. PMID: 19224863 Free PMC article. - Synphilin-1 isoforms in Parkinson's disease: regulation by phosphorylation and ubiquitylation.
Szargel R, Rott R, Engelender S. Szargel R, et al. Cell Mol Life Sci. 2008 Jan;65(1):80-8. doi: 10.1007/s00018-007-7343-0. Cell Mol Life Sci. 2008. PMID: 17982729 Free PMC article. Review. - Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
Eyal A, Engelender S. Eyal A, et al. Cell Cycle. 2006 Sep;5(18):2082-6. doi: 10.4161/cc.5.18.3209. Epub 2006 Sep 15. Cell Cycle. 2006. PMID: 16969096 Review.
Cited by
- Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model.
Smith WW, Liu Z, Liang Y, Masuda N, Swing DA, Jenkins NA, Copeland NG, Troncoso JC, Pletnikov M, Dawson TM, Martin LJ, Moran TH, Lee MK, Borchelt DR, Ross CA. Smith WW, et al. Hum Mol Genet. 2010 Jun 1;19(11):2087-98. doi: 10.1093/hmg/ddq086. Epub 2010 Feb 25. Hum Mol Genet. 2010. PMID: 20185556 Free PMC article. - α-Synuclein fate is determined by USP9X-regulated monoubiquitination.
Rott R, Szargel R, Haskin J, Bandopadhyay R, Lees AJ, Shani V, Engelender S. Rott R, et al. Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18666-71. doi: 10.1073/pnas.1105725108. Epub 2011 Nov 7. Proc Natl Acad Sci U S A. 2011. PMID: 22065755 Free PMC article. - Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications.
Zhong Q, Xiao X, Qiu Y, Xu Z, Chen C, Chong B, Zhao X, Hai S, Li S, An Z, Dai L. Zhong Q, et al. MedComm (2020). 2023 May 2;4(3):e261. doi: 10.1002/mco2.261. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37143582 Free PMC article. Review. - Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity.
Thellung S, Corsaro A, Nizzari M, Barbieri F, Florio T. Thellung S, et al. Int J Mol Sci. 2019 Feb 19;20(4):901. doi: 10.3390/ijms20040901. Int J Mol Sci. 2019. PMID: 30791416 Free PMC article. Review. - Molecular pathology of Lewy body diseases.
Beyer K, Domingo-Sàbat M, Ariza A. Beyer K, et al. Int J Mol Sci. 2009 Mar;10(3):724-45. doi: 10.3390/ijms10030724. Epub 2009 Feb 26. Int J Mol Sci. 2009. PMID: 19399218 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous